Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-016827
Filing Date
2024-02-12
Accepted
2024-02-12 20:40:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm245964d1_sc13g.htm SC 13G 37080
  Complete submission text file 0001104659-24-016827.txt   38710
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Subject) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93970 | Film No.: 24622239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 36F., NO. 68, SEC. 5, ZHONGXIAO E. RD., XINYI DISTRICT TAIPEI CITY F5 110
Business Address 36F., NO. 68, SEC. 5, ZHONGXIAO E. RD., XINYI DISTRICT TAIPEI CITY F5 110 886287805008
Lin Bioscience International Ltd. (Filed by) CIK: 0001965750 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G